Search

The shared CLIA lab aims to help diagnostics start-ups, including Australian-based Minomic, more rapidly enter the U.S. market

Latest technologies aim to improve speed, sensitivity and flexibility for clinical testing and research related to COVID-19, cell and gene therapy, autoimmune disease and drugs of abuse

Customers will benefit from enhanced development and manufacturing capabilities, including high-density microarray printing

Measurement of anti-S1/RBD antibodies, neutralizing antibodies targeting S1/RBD, and specific T-cells using EUROIMMUN tests supports evaluation of the immune reaction to SARS-CoV-2 following vaccination or infection

New kit enables researchers to generate more data in less time to support viral vector bioprocess analytics

Introduced at AACC, the VeraPrep Antibody Detection Kit enables researchers to measure antibodies against any antigen of interest in serum, plasma or saliva

Sartorius-Rebecca-Dubois.txt